Mitochondria | CHOP Research Institute


Published on
Nov 16, 2023
The Connor Initiative, a multimillion dollar gift from the Holveck Family, will support precision therapeutics for osteosarcoma and rare cancers.
Published on
Nov 13, 2023
Douglas C. Wallace, PhD, investigates the role of adaptive immunity in the etiology of Alzheimer’s disease (AD) and AD-related dementias.
Published on
Oct 13, 2023
In our weekly news roundup, Dr. Beverly Davidson received a $1 million grant to study Huntington’s disease. This and more on Cornerstone.
Published on
Sep 29, 2023
This week’s In The News reports on higher education vaccination policies, college athletes’ concussions, a new genetic disease, and zebrafish.
Published on
Aug 18, 2023
The FDA approved an oral drug, based on foundational research conducted at CHOP, to treat a rare, severe bone disease. More In The News.
Published on
Mar 2, 2023
With a grant from the Gates Foundation, CHOP researchers are working to determine the importance of mitochondria DNA variation in COVID-19 severity.
Published on
Dec 27, 2022
Featured Diversity Fellow Arnold Olali, PhD, is focused on understanding how mitochondria affect overall health.
Published on
Apr 1, 2022
Learn about earn about a regional research collaboration, prestigious awards, and listen to a special podcast series.
Published on
Sep 22, 2021
Marni Falk, MD, and Adam Resnick, PhD, to lead the Mitochondria and Cancer Connections (MC²) Research Program, a new CHOP research initiative.

The Wallace Laboratory investigates the role of mitochondria in human evolution, health, and disease.